Fingerprint
Dive into the research topics of 'The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial
Ali Ziada, Albaha Barqawi, L. Michael Glode, Marileila Varella-Garcia, Frances Crighton, Susan Majeski, Mark Rosenblum, Madeleine Kane, Lin Chen, E. David Crawford
Research output: Contribution to journal › Article › peer-review
141
Citations
(SciVal)